Correlation Between the Fasting Blood Glucose Level and the Severity of Clinical
Manifestation of Peripheral Neuropathy on Diabetic Patient
Santoso Jaeri*
Department of Medical Biology and Biochemistry, Faculty of Medicine, Universitas
Diponegoro Semarang, Indonesia
*Corresponding Author: Mario Carvi Nievas, Department of Medical Biology and Biochemistry, Faculty of Medicine, Universitas
Diponegoro Semarang, Indonesia.
Received:
June 13, 2023; Published: July 25, 2023
Abstract
Background: The prevalence of Diabetes Mellitus (DM) in 2017 was 8.8% and is predicted to increase to 9.9%. Diabetic peripheral
neuropathy is one of the common complications occurred in people with DM. There is controversy regarding the correlation of the
fasting blood glucose level with the severity of its manifestation.
Aim: To identify the correlation between the fasting blood glucose level and the severity of peripheral neuropathy on diabetic patient.
Methods: An analytic observational study using cross-sectional design from sixty-one patients with type 2 diabetes. The severity of
peripheral neuropathy clinical manifestation measured using Modified Toronto Clinical Neuropathy Score. The fasting blood glucose
levels measured from the intravenous blood after fasting for 8 hours. Data analyzed using statistic software SPSS 26. Bivariate correlation
test analyzed using spearman correlation coefficient.
Results: There is no correlation correlation between the fasting blood glucose level and severity of peripheral neuropathy on diabetic
patient (p = 0.875, r = -0.22).
Conclusion: The fasting blood glucose level does not correlate with the severity of peripheral neuropathy on diabetic patients
Keywords: Diabetes Mellitus; Fasting Blood Glucose; Modified Toronto Clinical Neuropathy Score; Peripheral Neuropathy
References
- World Health Organization. Diabetes (2020).
- Sarwar N., et al. “Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Emerging Risk Factors Collaboration”. Lancet9733 (2010): 2215-2222.
- Bourne RR., et al. “Causes of vision loss worldwide, 1990-2010: a systematic analysis”. Lancet Global Health6 (2013): e339-e349.
- United States Renal Data System. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases”. American Journal of Kidney Diseases (2014). USRDS annual data report: Epidemiology of kidney disease in the United States (2015): 188-210.
- Khawaja N., et al. “The prevalence and risk factors of peripheral neuropathy among patients with type 2 diabetes mellitus; the case of Jordan”. Diabetology and Metabolic Syndrome 8 (2018): 1–10.
- Kurniawan SN. “Patofisiologi Biomolekular Neuropati Diabetes”. Maj Kedokt Neuro4 (2012): 66–75.
- Standards Of Medical Care in Diabetes-2019. Riddle MC, editor. USA: American Diabetes Association (2019).
- IDF Diabetes Atlas 8th edition. Karuranga S, Fernandes J da R, Huang Y, Malanda B, editors”. International Diabetes Federation (2017): 3-145.
- Levterova B., et al. “Prevalence, and Impact of Peripheral Neuropathy on Quality of Life in Patients with Diabetes Mellitus Pilot Study”. Trakia Journal of Sciences1 (2018): 71–76.
- Oh SJ. “Clinical electromyography: nerve conduction studies. In: Nerve conduction in polyneuropathies”. Baltimore: Williams and Wilkins (2012): 579–591.
- Bansal V., et al. “Diabetic neuropathy”. Postgraduate Medical Journal 964 (2011): 95–100.
- World Health Organization. Diabetes (2020).
- Deshpande AD., et al. “Epidemiology of diabetes and diabetes-related complications”. Physical Therapy 11 (2008): 1254-1264.
- Holzer SE., et al. “Costs, and duration of care for lower extremity ulcers in patients with diabetes”. Clinical Therapeutics1 (1998): 169-181.
- Caputo GM., et al. “Assessment and management of foot disease in patients with diabetes”. The New England Journal of Medicine 13 (1994): 854-860.
- Mouri M and Badireddy M. “Hyperglycemia”. StatPearls Publishing (2020): 1-7.
- Liu X., et al. “The risk factors for diabetic peripheral neuropathy: A meta-analysis”. PLoS One2 (2019): e0212574.
- Azmiardi A., et al. “Factors Associated with Diabetic Peripheral Neuropathy among Patients with Type 2 Diabetes Mellitus in Surakarta, Central Java”. Indonesian Journal of Medicine4 (2019): 300-312.
- Callaghan BC., et al. “Enhanced glucose control for preventing and treating diabetic neuropathy”. Cochrane Database of Systematic Reviews 6 (2012): CD007543.
Citation
Copyright